U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07102888) titled 'A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis' on July 29.
Brief Summary: This study is to evaluate the safety, tolerability, pharmacokinetics and efficacy of RSS0393 topical ointment in the treatment of plaque psoriasis in children and adolescents.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Plaque Psoriasis in Children
Plaque Psoriasis in Adolescents
Intervention:
DRUG: RSS0393 Ointment
RSS0393 ointment.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Disclaimer: Curated by...